Stevanato Group Spa
STVN
Get informed when a big investor buys or sells
+ FollowMarket Cap$5.23B
Close$
$3.64
81.2% downside
Current Fair Value
81.2% downsideOvervalued by 81.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $5.23 Billion |
|---|---|
| Enterprise Value | $5.66 Billion |
| Dividend Yield | $0.06 (0.32%) |
| Earnings per Share | $0.49 |
| Beta | 0.78 |
| Outstanding Shares | 273,003,694 |
Return
| Return on Equity | 9.21% |
|---|---|
| Return on Assets | 5.46% |
| Return on Invested Capital | 9.88% |
Valuation & Multiples
| P/E Ratio | 32.86 |
|---|---|
| PEG | 576.32 |
| Price to Sales | 4.85 |
| Price to Book Ratio | 3.88 |
| Enterprise Value to Revenue | 4.72 |
| Enterprise Value to EBIT | 28.31 |
| Enterprise Value to Net Income | 40 |
| Total Debt to Enterprise | 0.1 |
| Debt to Equity | 0.35 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 14, 2026
EPS Estimate
$0.12
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 4, 2026
EPS Estimate
$0.14
Average shareholder expectationRevenue Estimate
$340.58 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.78%▼ 15.54% |
|---|---|
| Total Invested | $38.72M▼ 93.68% |
| Investors Holding | 14▼ 122.00% |
ESG Score
No data
About Stevanato Group Spa
Founded in 1949, Stevanato Group is a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. The Group delivers an integrated, end-to-end por...